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Abstract  39 
Down syndrome is an intellectual disability disorder in which language and, 40 
specifically, verbal fluency are strongly impaired domains; nearly all adults show 41 
neuropathology of Alzheimer’s disease, including amyloid deposition by their fifth 42 
decade of life. In the general population, verbal fluency deficits are considered a strong 43 
Alzheimer’s disease predictor being the Semantic Verbal Fluency Task (SVFT) a useful 44 
tool for enhancing early diagnostic. However, there is a lack of information about the 45 
association between the semantic verbal fluency pattern (SVFP) and the biological 46 
amyloidosis markers in Down syndrome. In the current study, we used the SVFT in 47 
young adults with Down syndrome to characterize their SVFP, assessing total generated 48 
words, clustering, and switching. We then explored its association with early indicators 49 
of dementia, adaptive behavior and amyloidosis biomarkers, using the Dementia 50 
Questionnaire for Persons with Intellectual Disability (DMR), the Adaptive Behavior 51 
Assessment System-Second Edition (ABAS-II), and plasma levels of Aβ peptides (Aβ40 52 
and Aβ42), as a potent biomarker of Alzheimer's disease. In Down syndrome, worse 53 
performance in SVFT and poorer communication skills were associated with higher 54 
plasma Aβ42 concentrations, a higher DMR score and impaired communication skills 55 
(ABAS–II). The total word production and switching ability in SVFT were good 56 
indicators of plasma Aβ42 concentration. In conclusion, we propose the SVFT as a good 57 
screening test for early detection of dementia and amyloidosis in young adults with 58 
Down syndrome.  59 
Introduction 60 
Adults with Down syndrome (DS) have a high risk for the development of early onset 61 
dementia and invariably develop senile plaques, composed of β-amyloid peptide (Aβ), 62 
indistinguishable from the histopathology of sporadic Alzheimer's disease (AD) 63 
(Rumble et al., 1989). Plaques can be found in almost all adults from 35-40 years of age 64 
(Zigman et al., 2008), and the presence of Aβ oligomers can be detected as early as 65 
during fetal development (Lott & Dierssen, 2010; Teller et al., 1996), although the 66 
clinical symptoms clearly differ from those observed in AD in general population.  67 
The increase in lifespan in the DS population has made the early detection of dementia 68 
of Alzheimer’s type a major objective of researchers and clinicians. In the general 69 
population impairments in semantic fluency exist prior to the clinical diagnosis of AD 70 
(Vogel, Gade, Stokholm, & Waldemar, 2005). Specifically, patients with AD exhibit 71 
important deficits in both semantic and phonemic fluency, being the former the most 72 
impaired (Canning, Leach, Stuss, Ngo, & Black, 2004; Cerhan et al., 2002; Henry, 73 
Crawford, & Phillips, 2004; Taylor, Salmon, Monsch, & Brugger, 2005). Thus, 74 
alterations in clustering and switching abilities during the performance of a semantic 75 
verbal fluency task (SVFT) are considered early predictors of the development of AD in 76 
the general population (Palmer et al., 2003; Romero et al., 2008).  77 
Conversely, even though research on DS has substantiated language and verbal fluency 78 
as one of the most impaired domains (Palmer, Bäckman, Winblad, & Fratiglioni, 2003) 79 
influencing cognitive-related outcomes and daily living functionality (de Sola et al., 80 
2015; Edgin et al., 2010), there is a paucity of information about the verbal fluency 81 
pattern in DS young adults. To our knowledge, only two studies have reported the 82 
semantic verbal fluency pattern (SVFP) in DS, one in pediatric population, in which a 83 
reduced productivity of words and switching was shown in DS subjects compared to 84 
age-matched controls (Nash & Snowling, 2008) suggesting less efficient retrieval 85 
strategies. The second one in adult population with learning disabilities (Rowe, 86 
Lavender, & Turk, 2006), showed reduced word production, but the responses were 87 
only analyzed accounting for total number of correct words, regardless of performance 88 
in retrieval strategies such as clustering and switching.  89 
To date AD conversion in aged DS subjects is mainly analyzed by measuring plasma 90 
Aβ concentrations. Several studies have shown increased concentrations of both Aβ40 91 
and Aβ42 in young DS compared to control population (Head et al., 2011; Mehta et al., 92 
2003) and most found higher concentrations of Aβ42 in those DS individuals that were 93 
either demented or developed dementia at follow-up (Coppus et al., 2012; Prasher et al., 94 
2010; Schupf et al., 2007). Some correlations have also been found between high Aβ40 95 
plasma levels and dementia status, and between increases in Aβ40 and decreases of Aβ42 96 
and risk of dementia (Coppus et al., 2012; Head et al., 2011; Schupf et al., 2010; Schupf 97 
et al., 2007). Interestingly, most studies report no correlation between age and Aβ42 98 
levels (Head et al., 2011; Prasher et al., 2010).  99 
In the current study, we aimed at characterizing the SVFP including clustering and 100 
switching abilities in adults with DS in comparison to age-matched general population. 101 
To this aim, we used the SVFT that requires verbal abilities, search and retrieval skills, 102 
adequate processing speed, and the capacity to inhibit inappropriate responses (Henry & 103 
Phillips, 2006). The total number of words and the clustering, which measures the way 104 
these words are grouped by different semantic categories (i.e.: pets, farm, aquatic 105 
animal etc.), provide an indirect measure of the organization of semantic 106 
representations. On the other hand, the use of retrieval strategies, such as switching 107 
from one semantic category group of words to a new one, yields information about the 108 
set shifting ability, an executive skill related to the integrity of the frontal lobes. We 109 
then explored the association of SVFT performance with early indicators of dementia, 110 
adaptive behavior and amyloidosis biomarkers (Aβ40 and Aβ42).  111 
1. Material and Methods  112 
1.1. Participants 113 
 114 
The sample was drawn from the baseline visit of a clinical trial (TESDAD Study 115 
ClinicalTrials.gov Identifier: NCT01699711). Participants enrolled in our cross-116 
sectional study (n=50) were young adults (aged 17 to 34 years) of both genders with DS 117 
(complete trisomy 21, mosaic or translocation). Subjects with neurological disease other 118 
than DS (epilepsy, cerebral palsy, hemiplegia, central nervous system infection with 119 
neurological deficit), relevant medical disease, unstable co-morbid mental disorder 120 
(anxiety disorder, depression, obsessive compulsive disorder), or undergoing any 121 
treatment that could interfere with cognitive function or alter key biomarker analyzed 122 
were excluded from the study.  Also, exclusion criteria included subjects with severe 123 
language deficit (significant speech and/or comprehension limitations), behavioral 124 
disturbances and/or poor level of collaboration during the assessment but no subjects 125 
were excluded from the analysis by this criterion.  126 
 127 
To determine the gap in cognitive performance between DS subjects and healthy adults 128 
a comparison group, matched for age (mean age: 22.6 ± 3.8) was included 59 young 129 
healthy adults of both genders. These participants were assessed in previous 130 
neuropsychological studies (de Sola et al., 2008; Fagundo et al., 2010). Healthy 131 
volunteers were excluded if they had neurological or relevant medical diseases, or if 132 
they had been diagnosed with a psychiatric disorder following DSM-IV criteria. Whilst 133 
prevailing methodology compares DS subjects to healthy controls of the same “mental 134 
age” to provide an index of global level of mental functioning (Edgin, Pennington, & 135 
Mervis, 2010; Finestack & Abbeduto, 2010), this perspective is not useful for 136 
characterizing specific capacities (de Sola et al., 2015, Costanzo et al., 2013).  137 
 138 
The study was conducted in accordance with the Declaration of Helsinki and Spanish 139 
laws concerning data privacy. The protocol was approved by the Ethical Committee of 140 
the Parc de Salut Mar of Barcelona (CEIC-PSMAR).  Upon arrival at the research 141 
centre (Hospital del Mar Medical Research Institute-IMIM), participants, parents and 142 
legal guardians (in case of legal incapacitation) were informed of the ensuing protocol 143 
and they gave their written informed consent before participating. 144 
 145 
1.2. Procedure 146 
Semantic verbal fluency pattern 147 
We used the Semantic verbal fluency task (SVFT; (Benton, Hamsher, & Sivan, 1976) as 148 
a measure of semantic memory and executive functioning. Three outcome variables 149 
were obtained: (i) the total number of correctly generated words in 60 seconds, and the 150 
percentage of words generated every 15 seconds; (ii) errors committed including 151 
intrusions (words not belonging to the specified semantic category), perseverations and 152 
repetitions (same words or same words with different endings); and (iii) clustering and 153 
switching measures that were obtained to determine the strategies used to perform the 154 
task. Mean cluster size was the main dependent variable for clustering, whereas number 155 
of switches was the main dependent variable for switching (Troyer, Moscovitch, & 156 
Winocur, 1997; Troyer, 2000). A cluster was defined as any series of two or more 157 
successively produced words belonging to the same semantic subcategory, determined a 158 
priori (Fagundo et al., 2010). Cluster size was computed by adding up series of words 159 
from the same subcategory starting from the second word within each cluster (i.e. a 160 
three-word cluster has a size of two). The number of switches was defined and 161 
computed as the number of times the participant changed from one cluster to another. 162 
Two clusters may also be overlapping, for example, from “farm animals” to “birds” in 163 
“cow–pig–chicken–pigeon–eagle.” Here, one switch is made between the cluster “cow–164 
pig–chicken” and “chicken–pigeon–eagle.” The computation of number of switches 165 
included single-word clusters. An inter-rater reliability analysis was performed and the 166 
reliability studied by means of the intra-class correlation coefficient (ICC) was high 167 
with values ranging from 0.89 to 0.98. 168 
Intellectual quotient IQ 169 
The intellectual quotient estimation was assessed with The Kaufman Brief Intelligence 170 
Test (Kaufman, 1990).   171 
 172 
Functional measures 173 
The Adaptive Behavior Assessment System-Second Edition (ABAS-II, adult version;( 174 
Harrison & Oakland, 2003; 2011) for evaluating adaptive skills in people with 175 
intellectual disabilities and the Dementia Questionnaire for Persons with Intellectual 176 
Disability (Evenhuis HM, Kengen MMF, 2006) previously named Dementia 177 
Questionnaire for persons with Mental retardation). The DMR is a self-reported 178 
questionnaire about daily living abilities, which measures specific memory and 179 
orientation cognitive skills and social deterioration as a result of dementia and/or severe 180 
sensory or psychiatric problems. It consists of 50 items and eight subscales. Combined 181 
scores on the first three subscales (Short-term memory, Long-term memory and 182 
Orientation) are presented as the Sum of Cognitive Scores (SCS). Combined scores on 183 
subscales 4 through to 8 (Speech, Practical skills, Mood, Activity and Interest, and 184 
Behavioral disturbance) are presented as the Sum of Social Scores (SOS).  Higher 185 
scores in DMR reflect a worse state, while higher punctuations in ABAS-II reflect a 186 
better adaptive behavior.  187 
Both questionnaires were given to the caregivers for completion while participants 188 
completed the neuropsychological testing. We ensured they understood how to 189 
complete the questionnaires and solved all doubts before and after completion, and 190 
checked that all questions were filled.  191 
Plasma Aβ measurement   192 
Overnight fasting blood samples were collected on site by a qualified nurse, during the 193 
morning hours. The blood was drawn into 8 mL Heparin Lithium tubes (B&D, UK), 194 
centrifuged at 4ºC for 15 minutes at 3,000 rpm, and the plasma was distributed in 195 
aliquots and stored at -70ºC until analysis. Samples (only for DS subjects) were 196 
analyzed for plasma Aβ concentrations, using Inno-bia Plasma Aβ forms (Aβ40 and 197 
Aβ42, truncated Aβ40 and Aβ42 not reported) assay (Innogenetics, Fujirebio) following 198 
the manufacturer instructions. The plaques were read in a Bio-Plex 200 Systems (Bio-199 
Rad) instrument, and the standard curves were fitted using the provided software 200 
(Bioplex Manager 6.1).  201 
Statistical analysis 202 
Results are described by means of measures of both central tendency (mean and 203 
median) and variability (standard deviation and range) for numeric variables, and 204 
absolute and relative frequencies for categorical variables. In the case of the IQ, only the 205 
median is reported because no distinction is made of values below 40. The differences 206 
between DS and healthy groups with respect to semantic verbal fluency performance are 207 
quantified by means of the standardized mean difference (Cohen’s d). The computation 208 
of all correlations of interest was done using Pearson’s correlation coefficient. 209 
ANCOVA models were used to study the associations in DS between semantic verbal 210 
fluency outcomes, other cognitive and functional measures, and AD biomarkers, on one 211 
hand, and gender, IQ, and age, on the other hand. For these analyses, the IQ was 212 
categorized into two groups: mild/moderate (IQ ≥ 40) and severe (IQ < 40) within the 213 
range of intellectual disability (ID) level.  214 
Statistical significance was set at 0.05. All statistical analyses were performed using the 215 
statistical software packages SPSS (Version 18.0; SPSS Inc., Chicago, IL, USA) and R 216 
(Version 3.2.1; The R Foundation for Statistical Computing, Vienna, Austria). 217 
2. Results 218 
2.1. Descriptive demographic and clinical data of the participants 219 
In our DS sample, 48% individuals were male and the mean age was 23.6 years 220 
(standard deviation (SD): 4.5 years; range: 17-34 years). The median IQ was 41 (38% 221 
with IQ less than 40) and a maximum IQ of 70, whereas the mean K-BIT standardized 222 
score was 103 (SD: 14.9; range: 80-151). In terms of gender, the median IQ among 223 
males was 40 (IQ less than 40: 37.5%; maximum: 66) and among females 41.5 (IQ less 224 
than 40: 38.5%; maximum: 70), whereas the mean K-BIT standardized scores were 101 225 
(SD: 15.6; range: 80 - 144) and 105 (SD: 14.3; range: 80 - 151), respectively. 226 
Concerning the DS karyotypes, the sample showed the usual proportion for this 227 
population, with most individuals with full trisomy 21 (48 simple trisomies, one 228 
translocation, and one mosaic). Regarding Aβ plasma concentrations, the mean Aβ40 229 
concentration was 270.9 pg/mL [SD: 50.8; range: 174-439.3] and the mean Aβ42 was 41  230 
pg/mL [SD: 10; range: 21.5-60.9].  231 
 232 
Table 1. Cognitive performance in DS individuals compared to standard norms. The 233 
standardized mean differences are calculated using Cohen’s d. Age range: DS: 17-34, 234 
Reference standard norms 18-33 Sample size: DS: n=51, Reference Standard norm:  235 
n=59.   236 
 237 
 238 
2.2. Semantic verbal fluency performance in DS individuals compared to 239 
standard norms 240 
Descriptive analyses, Cohen effect size differences (d), and confidence intervals (95% 241 
CI) of fluency task performance in DS individuals and age-matched standard norms are 242 
summarized in Table 1. Our results show that in DS switching correlated more strongly 243 
than clustering with the total number of words generated (See Table 2). We found no 244 
correlation between the percentage of words produced in the first 15 and last 45 245 
seconds, with the total number of words. The mean percentage of words produced in the 246 
first 15 seconds was 37.8%. 247 
 Down syndrome  
Reference standard 
norms 
Standardized 
Mean Differences 
 
Mean (SD) 
Range 
(min-max) Mean (SD) 
Range 
(min-max) d 95% -CI 
Verbal Fluency       
Number of correct 
words in 60’ 
9.4 (4.1) 1–20 25.1 (5.7) 11-38 -3.13 [-3.69, -2.57] 
Percentage of correct 
words 0-15’ 
39.2 (16.6) 0-100 39.6 (7.9) 25-54 -0.03 [-0.46, 0.4] 
Percentage of correct 
words 16-30 
28.1 (12.3) 0-50 22.7 (6.5) 14-39 0.53 [0.09, 0.96] 
Percentage of correct 
words 31-45 
16.4 (12.4) 0-50 18.6 (5.8) 5-32 -0.22 [-0.65, 0.21] 
Percentage of correct 
words 46-60 
17.1 (12.0) 0-60 18.6 (9.5) 0-46 -0.14 [-0.56, 0.29] 
Number of switches 4.3 (2.5) 0 – 13 7.4 (2.1) 3-11 -1.4 [-1.82, -0.97] 
Mean cluster size 1.1 (0.8) 0 – 3.3 2.8 (0.9) 1.4-6.6 -1.93 [-2.39, -1.46] 
Table 2. Correlation between fluency strategies and the total number of words produced 248 
(Pearson’s correlation coefficient). 249 
 250 
On the contrary, in age-matched healthy population there is a stronger correlation 251 
between clustering and the total number of generated words, while there is no 252 
correlation between switching and the total number of words produced. Besides, we 253 
found a negative correlation between the percentage of words produced in the first 15 254 
seconds (mean percentage= 39.6) and the total number of words, and a positive 255 
correlation between the percentage of words produced during the last 45 seconds and 256 
the total number of words, indicating a more extensive lexicon in this population. 257 
2.3. Association between IQ, gender and age, and semantic verbal fluency 258 
outcomes in DS 259 
ANCOVA models were applied to analyze the association between the IQ, gender, and 260 
age and the semantic verbal fluency performance of DS individuals. As shown in Table 261 
3, no statistically significant associations were found between IQ, age and gender, and 262 
the verbal fluency pattern in the DS group.  263 
Table 3. Association between the verbal fluency pattern and the intellectual quotient 264 
(IQ), sex and age in DS individuals. Parameter estimates, standard errors (SE), and p-265 
values are obtained from ANCOVA models. 266 
 267 
 268 
 269 
 270 
 Total correct words 
Down syndrome Reference standard norms 
 
Correlation; 95%-CI p-value Correlation; 95%-CI p-value 
Number of switches 0.73; [0.57, 0.84] < 0.001 0.17; [-0.1, 0.41] 0.244 
Mean cluster size 0.3; [0.02, 0.53] 0.039 0.49; [0.26, 0.67] < 0.001 
Percentage of animals in the 
first 15 s 0.03; [-0.25, 0.31] 0.84 -0.54; [-0.73, -0.25] 0.001 
Percentage of animals in the 
last 45 s 0.11; [-0.18, 0.38] 0.453 0.51; [0.22, 0.72] 0.001 
 
IQ (< 40 vs. > 40) Sex (Women vs. men) Age 
Verbal fluency 
outcomes Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Number of correct 
words in 60 sec -1.04 (1.18) 0.386 0. 45 (1.17) 0.704 0.18 (0.13) 0.190 
Number of switches 0.25 (0.73) 0.736 0.44 (0.72) 0.547 0.04 (0.08) 0.663 
Mean cluster size -0.36 (0.23) 0.112 -0.07 (0.22) 0.750 0.02 (0.03) 0.488 
2.4. Association between IQ, gender, and age and AD biomarkers in DS 271 
 272 
ANCOVA models were applied to analyze the association between IQ, gender, and age, 273 
on one hand, and Aβ40, Aβ42, Aβ42/40 plasma concentrations of DS individuals, on the 274 
other hand. We found a statistically significant association between IQ and Aβ40. The 275 
negative parameter estimate indicates lower Aβ40 concentrations among DS individuals 276 
of the same age and sex with an IQ < 40 compared with those with an IQ > 40 (Table 277 
4).  278 
Table 4. Association between Aβ concentrations and intellectual quotient (IQ), sex, and 279 
age in DS individuals. Parameter estimates, standard errors (SE), and p-values are 280 
obtained from ANCOVA models. 281 
2.5. Associations of Aβ42 concentration with cognitive and dementia rating 282 
functional outcomes 283 
ANCOVA models were applied to analyze the association between Aβ42 concentration 284 
and both semantic verbal fluency outcomes and functional state among DS individuals. 285 
The models were adjusted for IQ, sex, and age (Table 5). Individuals with higher 286 
concentrations of Aβ42 produced lower number of correct words and lower number of 287 
switches. Regarding adaptive behavior, subjects with higher Aβ42 plasma concentrations 288 
had lower scores in the subscale “Communication skills” of the ABAS questionnaire.  289 
Concerning dementia rating, higher Aβ42 plasma concentrations were associated with 290 
higher DMR total score; see Figure 1 for graphical representations of the statistically 291 
significant associations. 292 
Table 5. Association between Aβ42 concentration and cognitive and functional measure. 293 
Parameter estimates, standard errors (SE), and p-values are obtained from ANCOVA 294 
models adjusted for IQ, age, and sex. 295 
 296 
 
IQ (< 40 vs. > 40) Sex (Women vs. men) Age 
Aβ concentrations Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Aβ42 -2.05 (2.97) 0.495 2.12 (2.94) 0.475 -0.21 (0.33) 0.527 
Aβ40 -38.2 (14.6) 0.012 19.9 (14.2) 0.167 -0.26 (1.59) 0.873 
Aβ40/42 0.007 (0.013) 0.564 0.004 (0.012) 0.758 -0.0002 (0.001) 0.893 
 Estimate (SE) p 
Cognitive performance in SVFT   
Number of correct words in 60’ -0.187 (0.052) < 0.001 
Number of switches -0.085 (0.035) 0.018 
Mean cluster size -0.006 (0.011) 0.582 
Functional outcomes   
ABAS adaptive behavior: communication skills -0.532 (0.158) 0.001 
DMR total score 0.366 (0.113) 0.002 
 297 
Figure 1. Verbal fluency and functional measures as a function of Aβ42 concentration. 298 
Correlations are shown for Aβ42 and Upper panel: number of correct words (left) and 299 
number of switches (right). Lower panel: ABAS adaptive behavior (left) and DMR total 300 
score (right). The figures include the regression lines from the corresponding linear 301 
regression models. 302 
2.6. Correlation between fluency measures and functional outcomes 303 
 304 
The total number of words produced in one minute and switching have both a positive 305 
correlation with communication skills and a negative correlation with the DMR total 306 
score. Furthermore, the total number of words produced in one minute is positively 307 
correlated with the ABAS total score (Table 6). 308 
Table 6. Correlation between cognitive and functional variables measured using 309 
Pearson’s correlation coefficient. 310 
 
DMR total ABAS total 
ABAS 
 Communication skills 
Correlation; 95%-CI p-value 
Correlation; 95%-
CI p-value 
Correlation; 95%-
CI p-value 
Number of correct 
words in 60’ -0.5; [-0.68, -0.25] < 0.001 0.32; [0.05, 0.55] 0.024 0.45; [0.2, 0.65] 0.001 
Number of 
switches -0.39; [-0.6, -0.12] 0.006 0.21; [-0.07, 0.46] 0.144 0.28; [0.01, 0.52] 0.046 
Mean cluster size -0.14; [-0.41, 0.14] 0.328 0.13; [-0.15, 0.4] 0.36 0.22; [-0.06, 0.47] 0.127 
3. Discussion 311 
Our study has found an association between the SVFP, dementia rates, and adaptive 312 
behavior related to communication skills in young adults with DS. Moreover, worse 313 
semantic fluency, higher dementia rates, and poor adaptive behavior and 314 
communication skills were associated to higher plasma concentrations of an AD 315 
biomarker (Aβ42). 316 
The observed associations between cognitive, functional, and biological parameters 317 
suggest that SVF assessment could be used a screening test for early detection of early 318 
symptoms of dementia DS. Furthermore, our study shows for the first time clear 319 
differences in the SVFP of a DS young adult population compared to healthy age-320 
matched individuals. 321 
3.1. Fluency deficits in young Down syndrome adults 322 
Impairment of verbal fluency, as estimated by lexical knowledge, is a feature of DS 323 
(Rowe, Lavender, & Turk, 2006). Our results showed a reduction of switching and 324 
cluster size as compared to the age-matched group, possibly due to a worse semantic 325 
knowledge. This profile is similar to the so called dysexecutive syndrome, described as 326 
a common pattern of dysfunction in executive functions such as planning, abstract 327 
thinking, flexibility, and behavioural control (Wilson, Evans, Emslie, Alderman, & 328 
Burgess, 1998). A dysexecutive syndrome has already been reported in DS (de Sola et 329 
al., 2015; Lanfranchi, Jerman, Dal Pont, Alberti, & Vianello, 2010; Rowe et al., 2006), 330 
and has been related to the reduced volume of the prefrontal cortex reported in 331 
neuroimaging studies (Carducci et al., 2013; Raz et al., 1995; White, Alkire, & Haier, 332 
2003), in particular affecting the anterior cingulate gyrus, medial, and dorsolateral 333 
prefrontal cortices (Contestabile, Benfenati, & Gasparini, 2010; Lott & Dierssen, 2010). 334 
These areas actively contribute to mnemonic processing and executive control in 335 
euploid individuals (Blumenfeld, Parks, Yonelinas, & Ranganath, 2011; Braver, 2001; 336 
Wager & Smith, 2003), and, thus, the generalized impairment of high order frontal-337 
dependent processes has a negative influence on SVFP which depends on both 338 
mnemonic and executive processes.  339 
Similarly to what is observed in healthy population in our DS group the word 340 
production decreases significantly with time, although in the DS group we detected the 341 
wide individual variability typically shown in the DS population. The production 342 
decrease over time can be explained according to the model of lexical organization 343 
(Crowe, 1996), which states that there are two types of storages, namely: (1) a long-344 
term storage (‘topicon’) which is readily accessible and contains common words, and 345 
(2) a more extensive lexicon which is searched after the ‘topicon’ is exhausted. Thus, 346 
successful performance on a verbal fluency task seems to be subjected to the 347 
effectiveness of both automatic and controlled processing (Crowe, 1998; Hurks et al., 348 
2006). In our DS sample, subjects are not differentiating between using automatic 349 
processing and instead, they access to the pool of frequently used words, but when this 350 
is exhausted, they fail in using controlled attentional searching retrieval processes that 351 
involve executive strategies with high impact on total word production, such as 352 
switching. Word production in normative age matched population also decreases over 353 
time, paired with a high percentage of words produced in the first 15 seconds as 354 
reported in previous studies (Villodre et al., 2006). However, their topicon and lexicon 355 
are richer than DS due to better semantic knowledge (clustering) and retrieval strategies 356 
(switching). 357 
3.2. Aβ plasma concentrations in young DS group 358 
Regarding the plasma concentrations of amyloid peptides, few studies have measured 359 
the concentrations of such biomarkers in young adults (Head et al., 2011; Mehta et al., 360 
2003), and those were performed in older populations. Compared to them, we obtained 361 
higher mean concentrations of Aβ42 (41 ±10 pg/mL), possibly due to the sensitivity of 362 
method we used. However, another study performed in younger DS subjects (mean 7.2 363 
± 3.8) obtained concentrations (31.6 ± 8.2 pg/mL) that were closer to our mean values 364 
(Mehta, Capone, Jewell, & Freedland, 2007). 365 
Contrary to previous studies in older DS populations (Head, 2011; Prasher, 2010; 366 
Schupf, 2010) that report a correlation of Aβ42 with age, in ours this is not present 367 
suggesting that factors other than age are affecting the Aβ42 production. 368 
In light of our results, the impact of these biomarkers and their evolution pattern should 369 
be studied throughout adulthood in DS, and not only in the elderly.   370 
3.3. Association between fluency performance and Aβ concentrations  371 
A large subset of aged individuals with DS develop clinical features of AD and some 372 
studies have suggested deficits in executive function (Ball et al., 2006; Holland et al., 373 
2000). In AD patients, AD was better predicted by the clustering ability in some reports 374 
(Fagundo et al., 2008), although others (Raoux et al., 2008) found a significant decline 375 
in switching along the early phase until the clinical diagnosis of AD dementia. In our 376 
DS population, switching and the total number of words are the verbal fluency markers 377 
that better correlate with the plasma Aβ42 concentrations. This observation supports the 378 
hypothesis that impaired switching abilities could explain the early decline in semantic 379 
fluency performance in an early state of AD. Moreover, the association between AD 380 
biomarkers and verbal fluency pattern is supported by the correlation that we found 381 
between Aβ concentrations, dementia ratings (DMR), and communication skills. We 382 
observed that higher concentrations of Aβ42 were associated to lower adaptive behavior 383 
and communication skills and higher DMR scores. In accordance, DMR can be 384 
considered useful detecting early symptoms of AD in DS. These results would also be 385 
in agreement with previous studies linking higher Aβ42 plasma concentrations in elderly 386 
DS with dementia or the development of dementia (Schupf, 2007; Coppus, 2012; 387 
Prasher, 2010). Furthermore, DMR scores were inversely correlated with the SVFP. 388 
This is interesting because, in our study, positive correlations were found between 389 
communication skills, semantic verbal fluency, and switching, as discussed above. 390 
Communication abilities are a compilation of cognitive and social processes such as 391 
comprehension, expression, and empathy. Semantic verbal fluency seems to be part of 392 
this compilation of abilities involved in verbal expression as forming part of 393 
communication skills. In our case, the DS subjects are not demented, but there is a clear 394 
correlation between higher Aβ42 and worse scores in functional variables that can be 395 
used to detect an early dementia state.  396 
 397 
 398 
3.4. Limitations 399 
The present study has several limitations. First, plasma measurements of Aβ 400 
concentrations remain controversial. Their high variability and lack of correlation with 401 
the observations of amyloidosis in the brain are some of the reasons leading some 402 
researchers to perform their measurements in CSF, that were not performed in our 403 
study. In our study, several peripheral tissues and cells, such as muscle and platelets, 404 
could be the source of peripheral Aβ (Toledo et al., 2014). However, in the context of 405 
clinical trials, as well as in clinical practice in general, it is worth improving the 406 
reliability of this blood measurement, as it is much less invasive than CSF extraction, as 407 
well as exploring its correlations with early cognitive symptoms of AD.  Second, we 408 
only compared the SVFT between the DS group and the age-matched group. The rest of 409 
assessments as dementia rates, adaptive behavior and Aβ concentrations are lacking a 410 
comparative group. Finally, the high number of statistical tests carried out may increase 411 
the probability of Type-1 errors. Nonetheless, no correction to control a family-wise 412 
significance level of 0.05 has been applied in order not to increase the probability of 413 
Type-2 errors.  414 
3.5. Conclusion 415 
 416 
Several studies have sought to understand the implications of changes in plasma Aβ 417 
concentrations with regard to the development of AD in DS using Mini Mental State 418 
Evaluation (MMSE), yet none has looked at the correlations between changes in 419 
concentrations and changes SVFP. Our results show an association between SVFP and 420 
early AD symptoms and plasma Aβ concentrations supporting the use of SVFT as a 421 
useful tool to detect DS subjects who are vulnerable to develop early onset AD.  422 
Our results may be taken as a first step for further studies to find easy and fast non-423 
invasive tools to predict the early onset of AD in DS population.   424 
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